8.98
price up icon3.82%   0.33
after-market アフターアワーズ: 8.98
loading
前日終値:
$8.65
開ける:
$8.87
24時間の取引高:
1.28M
Relative Volume:
0.55
時価総額:
$1.03B
収益:
$2.35B
当期純損益:
$-74.42M
株価収益率:
-9.5532
EPS:
-0.94
ネットキャッシュフロー:
$150.93M
1週間 パフォーマンス:
-2.71%
1か月 パフォーマンス:
-6.26%
6か月 パフォーマンス:
-59.91%
1年 パフォーマンス:
-70.20%
1日の値動き範囲:
Value
$8.87
$9.2098
1週間の範囲:
Value
$8.40
$9.22
52週間の値動き範囲:
Value
$8.23
$33.48

Evolent Health Inc Stock (EVH) Company Profile

Name
名前
Evolent Health Inc
Name
セクター
Healthcare (1179)
Name
電話
571-389-6000
Name
住所
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON
Name
職員
4,500
Name
Twitter
@EvolentHealth
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
EVH's Discussions on Twitter

EVH を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Health Information Services icon
EVH
Evolent Health Inc
8.98 1.03B 2.35B -74.42M 150.93M -0.94
Health Information Services icon
VEEV
Veeva Systems Inc
220.53 35.90B 2.75B 714.14M 1.09B 4.33
Health Information Services icon
DOCS
Doximity Inc
54.22 9.90B 516.85M 174.11M 217.38M 0.87
Health Information Services icon
HQY
Healthequity Inc
86.08 7.46B 1.15B 96.70M -161.99M 1.09
Health Information Services icon
TEM
Tempus Ai Inc
49.55 7.07B 640.44M -743.28M -206.93M -11.29
Health Information Services icon
WAY
Waystar Holding Corp
36.80 6.32B 906.14M -52.62M 89.62M -0.3621

Evolent Health Inc Stock (EVH) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-01-10 開始されました Needham Buy
2024-12-03 繰り返されました BTIG Research Buy
2024-11-08 ダウングレード Stephens Overweight → Equal-Weight
2024-10-11 開始されました KeyBanc Capital Markets Overweight
2024-08-09 アップグレード Truist Hold → Buy
2024-04-22 開始されました Citigroup Buy
2024-03-01 開始されました Oppenheimer Outperform
2024-01-03 開始されました Barclays Overweight
2023-12-06 開始されました JMP Securities Mkt Outperform
2023-10-16 開始されました UBS Buy
2023-04-12 開始されました Stephens Overweight
2022-11-01 開始されました Truist Hold
2022-07-29 開始されました RBC Capital Mkts Outperform
2022-03-30 開始されました Guggenheim Buy
2021-11-18 アップグレード JP Morgan Neutral → Overweight
2021-04-29 再開されました JP Morgan Neutral
2021-01-07 開始されました BTIG Research Buy
2020-07-06 ダウングレード KeyBanc Capital Markets Overweight → Sector Weight
2020-06-05 ダウングレード Goldman Buy → Neutral
2020-06-02 ダウングレード Cantor Fitzgerald Overweight → Neutral
2018-10-05 再開されました Leerink Partners Outperform
2018-06-04 開始されました Piper Jaffray Overweight
2018-04-24 再開されました JP Morgan Neutral
2017-09-20 開始されました KeyBanc Capital Mkts Overweight
2017-06-02 開始されました Robert W. Baird Outperform
2017-03-14 開始されました Oppenheimer Outperform
2017-01-13 アップグレード Wells Fargo Market Perform → Outperform
2016-10-28 再開されました JP Morgan Overweight
2016-08-05 繰り返されました FBR Capital Outperform
2016-07-26 開始されました Jefferies Buy
2016-07-13 繰り返されました FBR Capital Outperform
2016-03-29 開始されました FBR Capital Outperform
2016-01-06 開始されました Canaccord Genuity Buy
2015-06-30 開始されました Goldman Buy
2015-06-30 開始されました JP Morgan Overweight
2015-06-30 開始されました Leerink Partners Outperform
2015-06-30 開始されました Sun Trust Rbsn Humphrey Buy
すべてを表示

Evolent Health Inc (EVH) 最新ニュース

pulisher
Apr 22, 2025

Evolent Health Nominates Shawn Guertin to Board - TipRanks

Apr 22, 2025
pulisher
Apr 22, 2025

Evolent names Shawn Guertin as new independent nominee for election to its Board of Directors | EVH Stock News - GuruFocus

Apr 22, 2025
pulisher
Apr 22, 2025

Evolent Names Shawn Guertin As New Independent Nominee For Election To Its Board Of Directors - marketscreener.com

Apr 22, 2025
pulisher
Apr 22, 2025

Healthcare Finance Veteran Shawn Guertin Brings 40-Year Experience to Evolent Board Nomination - Stock Titan

Apr 22, 2025
pulisher
Apr 21, 2025

Molina Healthcare, Encompass Health, RadNet, Evolent Health, and Ibotta Shares Are Falling, What You Need To Know - Yahoo Finance

Apr 21, 2025
pulisher
Apr 20, 2025

Analysts’ Top Healthcare Picks: Evolent Health (EVH), Gilead Sciences (GILD) - The Globe and Mail

Apr 20, 2025
pulisher
Apr 17, 2025

Evolent Health Insiders Placed Bullish Bets Worth US$1.35m - Yahoo

Apr 17, 2025
pulisher
Apr 16, 2025

Evolent program achieves 20% reduction in use of low-value oncol - GuruFocus

Apr 16, 2025
pulisher
Apr 15, 2025

Evolent program achieves 20% reduction in use of low-value oncology regimens - PR Newswire

Apr 15, 2025
pulisher
Apr 15, 2025

Healthcare Breakthrough: Evolent Slashes Expensive Cancer Treatment Costs While Maintaining Care Quality - Stock Titan

Apr 15, 2025
pulisher
Apr 14, 2025

Benign Growth For Evolent Health, Inc. (NYSE:EVH) Underpins Its Share Price - simplywall.st

Apr 14, 2025
pulisher
Apr 11, 2025

Evolent To Release First Quarter 2025 Financial Results on Thurs - GuruFocus

Apr 11, 2025
pulisher
Apr 11, 2025

Evolent Health (EVH) Price Target Lowered by Truist Analyst Amid Market Uncertainty | EVH Stock News - GuruFocus

Apr 11, 2025
pulisher
Apr 10, 2025

Evolent To Release First Quarter 2025 Financial Results on Thursday, May 8, 2025 - The Malaysian Reserve

Apr 10, 2025
pulisher
Apr 10, 2025

The Analyst Verdict: Evolent Health In The Eyes Of 16 Experts - Benzinga

Apr 10, 2025
pulisher
Apr 10, 2025

1 Growth Stock to Stash and 2 to Keep Off Your Radar - The Globe and Mail

Apr 10, 2025
pulisher
Apr 10, 2025

Evolent Health price target lowered to $14 from $15 at Truist - TipRanks

Apr 10, 2025
pulisher
Apr 10, 2025

Truist Cuts Price Target on Evolent Health to $14 From $15, Keeps Buy Rating - marketscreener.com

Apr 10, 2025
pulisher
Apr 10, 2025

Indo-Asian News Service - Indo-Asian News Service (IANS)

Apr 10, 2025
pulisher
Apr 10, 2025

Evolent Health Sets Q1 Earnings Date: Key Financial Results and Conference Details Ahead - Stock Titan

Apr 10, 2025
pulisher
Apr 08, 2025

Evolent Health, Inc. (NYSE:EVH) Receives $17.71 Consensus Target Price from Brokerages - MarketBeat

Apr 08, 2025
pulisher
Apr 01, 2025

KeyBanc sees PRVA acquisition of EVH’s MSSP as unlikely but instructive - Investing.com Australia

Apr 01, 2025
pulisher
Apr 01, 2025

Evolent Health, Inc. (EVH): Among Stocks Insiders Were Buying In Q1 2025 - Yahoo

Apr 01, 2025
pulisher
Mar 31, 2025

20 Stocks Insiders Were Buying In Q1 2025 - Insider Monkey

Mar 31, 2025
pulisher
Mar 28, 2025

Is Evolent Health (EVH) About to Explode? - Insider Monkey

Mar 28, 2025
pulisher
Mar 27, 2025

12 Stocks That Are About to Explode - Insider Monkey

Mar 27, 2025
pulisher
Mar 25, 2025

Here’s What Challenged Evolent Health (EVH) Despite Strong Revenue Growth - Insider Monkey

Mar 25, 2025
pulisher
Mar 21, 2025

Evolent Health (NYSE:EVH) shareholders have endured a 69% loss from investing in the stock a year ago - Yahoo Finance

Mar 21, 2025
pulisher
Mar 20, 2025

When the Price of (EVH) Talks, People Listen - Stock Traders Daily

Mar 20, 2025
pulisher
Mar 20, 2025

1 Healthcare Stock on Our Watchlist and 2 to Turn Down - The Globe and Mail

Mar 20, 2025
pulisher
Mar 18, 2025

Evolent Health (EVH): Among Stocks Insiders Are Buying In March - Insider Monkey

Mar 18, 2025
pulisher
Mar 15, 2025

Evolent Health Co-Founder Acquires 13% More Stock - simplywall.st

Mar 15, 2025
pulisher
Mar 15, 2025

10 Stocks Insiders Are Buying In March - Insider Monkey

Mar 15, 2025
pulisher
Mar 14, 2025

Q4 Earnings Review: Healthcare Technology for Providers Stocks Led by Phreesia (NYSE:PHR) - The Globe and Mail

Mar 14, 2025
pulisher
Mar 14, 2025

Cardinal Health Adds Two Members to Its Board of Directors - HME Business

Mar 14, 2025
pulisher
Mar 13, 2025

Commit To Buy Evolent Health At $7.50, Earn 22.1% Annualized Using Options - Nasdaq

Mar 13, 2025
pulisher
Mar 11, 2025

Define Ventures Appoints Carolyn Magill as Venture Partner - Quantisnow

Mar 11, 2025
pulisher
Mar 11, 2025

Healthcare Powerhouse Carolyn Magill Joins $800M Define Ventures Leadership Team - StockTitan

Mar 11, 2025
pulisher
Mar 11, 2025

Evolent Health (NYSE:EVH) Given New $12.00 Price Target at JPMorgan Chase & Co. - Defense World

Mar 11, 2025
pulisher
Mar 11, 2025

Evolent Health, Inc. (NYSE:EVH) Receives Average Rating of “Buy” from Analysts - Defense World

Mar 11, 2025
pulisher
Mar 10, 2025

Evolent health director Brendan Springstubb acquires $139,050 in stock By Investing.com - Investing.com South Africa

Mar 10, 2025
pulisher
Mar 10, 2025

Evolent Health director Keck Kim buys $99,497 in stock By Investing.com - Investing.com South Africa

Mar 10, 2025
pulisher
Mar 10, 2025

Evolent Health director Glass Russell Monroe acquires $50,058 in stock By Investing.com - Investing.com South Africa

Mar 10, 2025
pulisher
Mar 10, 2025

Beyond The Numbers: 18 Analysts Discuss Evolent Health Stock - Benzinga

Mar 10, 2025
pulisher
Mar 10, 2025

Evolent health director Peter Grua acquires $99,470 in shares By Investing.com - Investing.com Australia

Mar 10, 2025
pulisher
Mar 10, 2025

Evolent Health CEO Seth Blackley purchases $497,577 in stock By Investing.com - Investing.com South Africa

Mar 10, 2025
pulisher
Mar 10, 2025

Evolent Health president Daniel McCarthy buys $99,470 in stock By Investing.com - Investing.com Canada

Mar 10, 2025
pulisher
Mar 10, 2025

Evolent health director Diane Holder buys shares worth $25,517 By Investing.com - Investing.com South Africa

Mar 10, 2025
pulisher
Mar 10, 2025

Evolent Health director Glass Russell Monroe acquires $50,058 in stock - Investing.com

Mar 10, 2025
pulisher
Mar 10, 2025

Evolent Health director Craig Barbarosh buys $17,620 in stock By Investing.com - Investing.com South Africa

Mar 10, 2025
pulisher
Mar 10, 2025

Evolent Health president Daniel McCarthy buys $99,470 in stock - Investing.com India

Mar 10, 2025

Evolent Health Inc (EVH) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$19.79
price up icon 1.12%
$25.46
price down icon 2.04%
$14.25
price down icon 1.38%
$23.39
price up icon 2.32%
$16.27
price up icon 1.12%
health_information_services WAY
$36.80
price up icon 3.81%
大文字化:     |  ボリューム (24 時間):